Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Feb. 23, 2018. Anthony Arnold.

Executive Summary

Anthony Arnold, CEO of device-maker SetPoint, says the drug industry is underestimating what patients really want when it comes to treating rheumatoid arthritis (RA). Check out what he said here.

"Pharma companies may underestimate how strong the patient demand for [an] alternative to biologics is. Patients are looking for something different and don’t want to be on drugs for the rest of their life." –Anthony Arnold, CEO, SetPoint

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT122245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel